Cardioprotective effects of tilianin in rat myocardial ischemia-reperfusion injury

Guo,Xinhong; Cao,Wenjiang; Yao,Jiaming; Yuan,Yong; Hong,Ye; Wang,Xinchun; Xing,Jianguo

doi:10.3892/mmr.2014.2954

Cardioprotective effects of tilianin in rat myocardial ischemia-reperfusion injury

Authors:
- Xinhong Guo
- Wenjiang Cao
- Jiaming Yao
- Yong Yuan
- Ye Hong
- Xinchun Wang
- Jianguo Xing
View Affiliations

Affiliations: Department of Pharmacy, First Affiliated Hospital of the Medical College, Shihezi University, Shihezi, Xinjiang 832000, P.R. China, Xinjiang Institute of Materia Medica, Ürümqi, Xinjiang 830004, P.R. China
Published online on: November 14, 2014 https://doi.org/10.3892/mmr.2014.2954
Pages: 2227-2233

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Tilianin, the main effective flavonoid monomer enriched from Dracocephalum moldavuca L., has been shown to have cardioprotective effects. However, the mechanism of tilianin cardioprotection remains largely unknown. The present study aimed to investigate the effects of tilianin preconditioning on myocardial ischemia/reperfusion injury and to analyze the possible mechanism of action. A total of 48 male Sprague Dawley rats were randomized into sham, model myocardial ischemia/reperfusion injury (MI/RI), propranolol hydrochloride positive control, and high‑, medium‑ and low‑dose tilianin groups (n=8 each). The rats in the tilianin groups were perfused with either 1.5, 2.5 or 5.0 mg/kg/d tilianin a week prior to surgery. The positive control group were perfused with 25 mg/kg/d propranolol. Saline was administered to the sham surgery and the MI/RI groups. The MI/RI model was established by ligating the left anterior descending coronary artery for 30 min, which was subsequently removed and the mice were observed for 120 min prior to sacrifice. Na+‑K+‑ATPase, Ca2+‑ATPase, nitric oxide (NO), nitric oxide synthase (NOS) and endothelial system‑related factors were analyzed using the respective detection kits. Immunohistochemistry was used to determine the expression levels of Bcl‑2 and Bax. Caspase‑3 activity was measured by quantitative polymerase chain reaction. The results showed that tilianin preconditioning significantly increased ATPase activity (P<0.01 and P<0.05) as compared with the model group. With regards to the regulation of endothelial function, significant decreases (P<0.01 and P<0.05) were detected in the serum NO levels and myocardial NOS activity when tilianin was administered to MI/RI rats, as compared with the model group, . In addition, the tilianin drug groups exhibited dose‑dependent reductions in the serum levels of endothelin 1 and thromboxane B2, and increases in the serum levels of calcitonin gene‑related peptide and 6‑keto prostaglandin F1a as compared with the model group (P<0.01 and P<0.05). Notably, the administration of tilianin significantly inhibited apoptosis, as evidenced by an increase in Bcl‑2 expression, and reductions in Bax and caspase‑3 mRNA expression levels (P<0.01 and P<0.05). These data indicate that pretreatment with tilianin exerts potent cardioprotective effects in rats with MI/RI. The anti‑MI/RI effects comprised relieving calcium overload, correction of energy metabolism, improvement of endothelial function and inhibiting cell apoptosis.

View Figures

View References

1	Kreatsoulas C and Anand SS: The impact of social determinants on cardiovascular disease. Can J Cardiol. 26:8C–13C. 2010. View Article : Google Scholar : PubMed/NCBI
2	Hausenloy DJ and Yellon DM: New directions for protecting the heart against ischemia-reperfusion injury: targeting the Reperfusion injury Salvage Kinase (RISK)-pathway. Cardiovasc Res. 61:448–460. 2004. View Article : Google Scholar : PubMed/NCBI
3	Ambrosio G and Tritto I: Reperfusion injury: experimental evidence and clinical implications. Am Heart J. 138:S69–S75. 1999. View Article : Google Scholar : PubMed/NCBI
4	Yellon DM and Baxter GF: Protecting the ischemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality? Heart. 83:381–387. 2000. View Article : Google Scholar : PubMed/NCBI
5	Li J, Zhang H and Zhang C: Role of inflammation in the regulation of coronary blood flow in ischemia and reperfusion: mechanisms and therapeutic implications. J Mol Cell Cardiol. 52:865–872. 2012. View Article : Google Scholar
6	Gottlieb RA: Cell death pathways in acute ischemia/reperfusion injury. J Cardiovasc Pharmacol Ther. 16:233–238. 2011. View Article : Google Scholar : PubMed/NCBI
7	Koenitze JR and Freeman BA: Redox signaling in inflammation: interactions of endogenous electrophiles and mitochondria in cardiovascular disease. Ann NY Acad Sci. 12:45–52. 2010. View Article : Google Scholar
8	Lakshmi SV, Padmaja G, Kuppusamy P and Kutala VK: Oxidative stress in cardiovascular disease. Indian J Biochem Biophys. 46:421–440. 2009.
9	Liou SF, Ke HJ, Hsu JH, et al: San-Huang-Xie-Xin Tang prevents rat hearts from ischemia/reperfusion-induced apoptosis through eNOS and MAPK pathways. Evid Based Complement Alternat. 2011:9150512011.
10	Feng Changgen and Li Qiong: The research of Dracocephalum moldavuca L. chemical constituents and pharmacological activities. J Tradit Chin Med. 25:1552003.
11	Yuan Yong, Xing Jian Guo, Zhang Yong Jun, et al: Determination the content of tilianin in Dracocephalum moldavuca L. by HPLC. Chin J Exp Tradit Med Formulae. 16:68–69. 2010.
12	Nam KH, Choi JH, Seo YJ, et al: Inhibitory effects of tilianin on the expression of inducible nitric oxide synthase in low density lipoprotein receptor deficiency mice. Exp Mol Med. 38:445–452. 2006. View Article : Google Scholar : PubMed/NCBI
13	Guo Xinhong, Cao Wenjiang, Fan Xinmei, et al: The protective effects of Tilianin on myocardial ischemia-reperfusion injury in rats. Chin J Exp Tradit Med Formulae. 13:169–172. 2013.
14	Zhao Q, Shao L, Hu X, Wu G, et al: Lipoxin A₄ preconditioning and postconditioning protect myocardial ischemia/reperfusion injury in rats. Mediators Inflamm. 2013:2313512013.
15	Wei Q, Yin Y, Xi M, et al: Antioxidant properties of magnesium lithospermate B contribute to the cardioprotection against myocardial ischemia/reperfusion injury in vivo and in vitro. J Tradit Chin Med. 33:85–91. 2013. View Article : Google Scholar
16	Ahmed LA, Salem HA, Attia AS and Agha AM: Pharmacological preconditioning with nicorandil and pioglitazone attenuates myocardial ischemia/reperfusion injury in rats. Eur J Pharmacol. 663:51–58. 2011. View Article : Google Scholar : PubMed/NCBI
17	Sun C, Liu C, Li S, et al: Overexpression of GEFT, a Rho family guanine nucleotide exchange factor, predicts poor prognosis in patients with rhabdomyosarcoma. Int J Clin Exp Pathol. 7:1606–1615. 2014.PubMed/NCBI
18	Zhao J, Xue W and Liang S: Protective effects of dracocephalum moldavica extracts on hypoxia/reoxygenation injury of cardiomyocytes in cultured neonatal rat. J Zhenzhou University (Med Sci). 2010:485–487. 2010.
19	Fan XM, Cao WJ, Xing JG, et al: Study on the protective effect of Dracocephalum total flavones against myocardial ischemia-reperfusion injury in rats. Chin Tradit Patent Med. 8:1625–1629. 2013.(In Chinese).
20	Rajadurai M and Stanely Mainzen Prince P: Preventive effect of naringin on cardiac markers, electrocardiographic patterns and lysosomal hydrolases in normal and isoproterenol-induced myocardial infarction in Wistar rats. Toxicol. 230:178–188. 2007. View Article : Google Scholar
21	Tian D, Dmitrieva RI, Doris PA, et al: Protein kinase M zeta regulation of Na/K ATPase: a persistent neuroprotective mechanism of ischemic preconditioning in hippocampal slice cultures. Brain Res. 1213:127–139. 2008. View Article : Google Scholar : PubMed/NCBI
22	Yorozuya T, Adachi N, Dote K, et al: Enhancement of Na⁺K⁺-ATPase and Ca²⁺-ATPase activities in multi-cycle ischemic preconditioning in rabbit hearts. Eur J Cardiothorac Surg. 26:981–987. 2004. View Article : Google Scholar : PubMed/NCBI
23	Yang G, Fang Z, Liu Y, et al: Protective effects of Chinese traditional medicine Buyang Huanwu decoction on myocardial injury. Evid Based Complement Alternat Med. 2011:9303242011. View Article : Google Scholar :
24	Razavi HM, Hamilton JA and Feng Q: Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure. Pharmacol Ther. 106:147–162. 2005. View Article : Google Scholar : PubMed/NCBI
25	Liu YN, Zhou ZM and Chen P: Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Clin Exp Pharmacol Physiol. 35:211–216. 2008.
26	Benigni A, Perico N and Remuzzi G: Endothelin antagonists and renal protection. J Cardiovasc Pharmacol. 35(4 Suppl 2): S75–S78. 2000. View Article : Google Scholar : PubMed/NCBI
27	de Hoon JN, Pickkers P, Smits P, et al: Calcitonin gene-related peptide: exploring its vasodilating mechanism of action in humans. Clin Pharmacol Ther. 73:312–321. 2003. View Article : Google Scholar : PubMed/NCBI
28	Ji L, Fu F, Zhang L, Liu W, Cai X, et al: Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress. Am J Physiol Endocrinol Metab. 298:E871–E880. 2010. View Article : Google Scholar : PubMed/NCBI
29	Moudgil R, Menon V, Xu Y, et al: Postischemic apoptosis and functional recovery after angiotensin II type 1 receptor blockade inisolated working rat hearts. J Hypertens. 19:1121–1129. 2001. View Article : Google Scholar : PubMed/NCBI
30	Chen Z, Chua CC, Ho YS, et al: Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am J Physiol Heart Circ Physiol. 280:H2313–H2320. 2001.PubMed/NCBI
31	Kumar D and Jugdutt BI: Apoptosis and oxidants in the heart. J Lab Clin Med. 142:288–297. 2003. View Article : Google Scholar : PubMed/NCBI
32	Nishihara M, Miura T, Miki T, et al: Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection. J Mol Cell Cordial. 43:564–570. 2007. View Article : Google Scholar
33	Zhang Q, Xiang J, Wang X, et al: Beta(2)-adrenoceptor agonist clenbuterol reduces infarct size and myocardial apoptosis after myocardial ischaemia/reperfusion in anaesthetized rats. Br J Pharmacol. 160:1561–1572. 2010. View Article : Google Scholar : PubMed/NCBI